Last edition
News about "Chiesi Group "
Chiesi Group to Acquire KalVista Pharmaceuticals to Expand Rare Disease Portfolio
Chiesi Group to acquire KalVista Pharmaceuticals for USD 1.9 billion, adding an oral on-demand therapy for hereditary angioedema and strengthening its global rare disease portfolio, with closing expected in Q3 2026.
Chiesi Group | 30/04/2026 | By News Bureau
Chiesi Group Expands Partnership with Bespak to Scale Up Low-Carbon Inhaler Manufacturing
Chiesi Group and Bespak have expanded their partnership to boost pMDI manufacturing capacity in the UK, supporting the rollout of next-generation Carbon Minimal Inhalers designed to significantly reduce environmental impact.
Chiesi Group | 13/03/2026 | By News Bureau | 141
Chiesi Acquires New Manufacturing Site in Milan with EUR 430 Million Investment
The EUR 430 million investment, spread between 2025 and 2030, will fund the redevelopment of a 124,000-square-meter industrial area, transforming it into an international center of excellence.
Chiesi Group | 28/03/2025 | By Aishwarya | 378
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy